Latest Risperidone Stories
Braeburn acquires six-month risperidone implant from Endo Pharmaceuticals; Phase 3 clinical trial planned for 2015 PRINCETON, N.J., May 1, 2015 /PRNewswire/ -- Braeburn Pharmaceuticals
Bernstein Liebhard LLP is representing Risperdal lawsuit plaintiffs in cases involving the medication’s alleged association with gynecomastia, and expects next month’s meeting to address issues
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
Bernstein Liebhard LLP is representing numerous plaintiffs who have filed Risperdal lawsuits in the Pennsylvania litigation, all of whom allegedly developed gynecomastia (male breast growth) due
Bernstein Liebhard LLP is representing numerous Risperdal plaintiffs in the Pennsylvania litigation, all of whom allegedly experienced excessive male breast growth due to their use of the antipsychotic
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
The Firm is looking forward to a status conference on March 19, 2015 that will discuss issues that affect hundreds of Risperdal lawsuit claimants. New York,
The Firm is representing numerous plaintiffs who have filed Risperdal lawsuits in Pennsylvania that allege the antipsychotic medication caused gynecomastia, or male breast development.
The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with
The Firm is currently representing numerous Risperdal lawsuit plaintiffs who raise similar questions regarding the tactics used to drive sales of the atypical antipsychotic medication.
- The abrogation of a law by a higher authority; annulment.